Description
(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011), a potent muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome.\nIC50 value:\nTarget: mAChR The general pharmacol. properties of this drug on the gastroinBiological Activity:(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011), a potent muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. \nIC50 value:\nTarget: mAChR The general pharmacol. properties of this drug on the gastro